SMTI PE Ratio & Valuation,Is SMTI Overvalued

SMTI Relative Valuation

SMTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SMTI is overvalued; if below, it's undervalued.

Historical Valuation

Sanara Medtech Inc (SMTI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.00 is considered Undervalued compared with the five-year average of -10.38. The fair price of Sanara Medtech Inc (SMTI) is between 28.27 to 78.23 according to relative valuation methord. Compared to the current price of 25.26 USD , Sanara Medtech Inc is Undervalued By 10.65%.

Relative Value

Fair Zone

28.27-78.23

Current Price：25.26

10.65%

Undervalued

22.34

0.00

EV/EBITDA

Sanara Medtech Inc. (SMTI) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 3.19. The thresholds are as follows: Strongly Undervalued below -25.06, Undervalued between -25.06 and -10.93, Fairly Valued between 17.32 and -10.93, Overvalued between 17.32 and 31.44, and Strongly Overvalued above 31.44. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

12.42

EV/EBIT

Sanara Medtech Inc. (SMTI) has a current EV/EBIT of 12.42. The 5-year average EV/EBIT is -8.88. The thresholds are as follows: Strongly Undervalued below -158.58, Undervalued between -158.58 and -83.73, Fairly Valued between 65.97 and -83.73, Overvalued between 65.97 and 140.82, and Strongly Overvalued above 140.82. The current Forward EV/EBIT of 12.42 falls within the Historic Trend Line -Fairly Valued range.

2.00

Sanara Medtech Inc. (SMTI) has a current PS of 2.00. The 5-year average PS is 4.63. The thresholds are as follows: Strongly Undervalued below -0.32, Undervalued between -0.32 and 2.15, Fairly Valued between 7.10 and 2.15, Overvalued between 7.10 and 9.58, and Strongly Overvalued above 9.58. The current Forward PS of 2.00 falls within the Undervalued range.

0.00

P/OCF

Sanara Medtech Inc. (SMTI) has a current P/OCF of 0.00. The 5-year average P/OCF is 36.99. The thresholds are as follows: Strongly Undervalued below -457.58, Undervalued between -457.58 and -210.29, Fairly Valued between 284.28 and -210.29, Overvalued between 284.28 and 531.56, and Strongly Overvalued above 531.56. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Sanara Medtech Inc. (SMTI) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Sanara Medtech Inc (SMTI) has a current Price-to-Book (P/B) ratio of 37.63. Compared to its 3-year average P/B ratio of 9.47 , the current P/B ratio is approximately 297.21% higher. Relative to its 5-year average P/B ratio of 10.14, the current P/B ratio is about 270.97% higher. Sanara Medtech Inc (SMTI) has a Forward Free Cash Flow (FCF) yield of approximately -0.36%. Compared to its 3-year average FCF yield of -1.04%, the current FCF yield is approximately -65.07% lower. Relative to its 5-year average FCF yield of -1.52% , the current FCF yield is about -75.99% lower.

37.63

P/B

Median3y

9.47

Median5y

10.14

-0.36

FCF Yield

Median3y

-1.04

Median5y

-1.52

Competitors Valuation Multiple

The average P/S ratio for SMTI's competitors is 2.25, providing a benchmark for relative valuation. Sanara Medtech Inc Corp (SMTI) exhibits a P/S ratio of 2.00, which is -10.87% above the industry average. Given its robust revenue growth of 21.51%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of SMTI decreased by 21.96% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -6.80 to -36.63.

The secondary factor is the Revenue Growth, contributed 21.51%to the performance.

Overall, the performance of SMTI in the past 1 year is driven by P/E Change. Which is more unsustainable.

21.51%

21.67M → 26.33M

Revenue Growth

-481.93%

-0.83 → 3.17

Margin Expansion

438.46%

-6.80 → -36.63

P/E Change

-21.96%

33.20 → 25.91

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Sanara Medtech Inc (SMTI) currently overvalued or undervalued?

What is Sanara Medtech Inc (SMTI) fair value?

SMTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Sanara Medtech Inc (SMTI) is between 28.27 to 78.23 according to relative valuation methord.

How does SMTI's valuation metrics compare to the industry average?

What is the current P/B ratio for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

As of Dec 15 2025, Sanara Medtech Inc (SMTI) has a P/B ratio of 37.63. This indicates that the market values SMTI at 37.63 times its book value.

What is the current FCF Yield for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

As of Dec 15 2025, Sanara Medtech Inc (SMTI) has a FCF Yield of -0.36%. This means that for every dollar of Sanara Medtech Inc’s market capitalization, the company generates -0.36 cents in free cash flow.

What is the current Forward P/E ratio for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

As of Dec 15 2025, Sanara Medtech Inc (SMTI) has a Forward P/E ratio of 22.34. This means the market is willing to pay $22.34 for every dollar of Sanara Medtech Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

As of Dec 15 2025, Sanara Medtech Inc (SMTI) has a Forward P/S ratio of 2.00. This means the market is valuing SMTI at $2.00 for every dollar of expected revenue over the next 12 months.

SMTI Valuation

SMTI Valuation

SMTI Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Sanara Medtech Inc (SMTI) currently overvalued or undervalued?

What is Sanara Medtech Inc (SMTI) fair value?

How does SMTI's valuation metrics compare to the industry average?

What is the current P/B ratio for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

What is the current FCF Yield for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

What is the current Forward P/E ratio for Sanara Medtech Inc (SMTI) as of Dec 15 2025?

What is the current Forward P/S ratio for Sanara Medtech Inc (SMTI) as of Dec 15 2025?